Type 2 diabetes mellitus and chronic heart failure: new treatment strategies
The article is devoted to the use of sodium-glucose cotransporter type 2 inhibitors in patients with type 2 diabetes mellitus and chronic heart failure drawing the example of clinical studies with Empagliflozin. Key results of the clinical studies are considered, thanks to which it can be argued tha...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Concilium Medicum
2021-12-01
|
Series: | КардиоСоматика |
Subjects: | |
Online Access: | https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/96366/70535 |